• News

Celgene backs four NCI Cancer Centers with $50M to create research consortium

  • Fierce Biotech
  • New York, NY
  • (June 22, 2022)

The Tisch Cancer Institute at Mount Sinai and three other National Cancer Institute-designated cancer centers together receive $50 million from pharmaceutical company Celgene to form a research consortium.

Learn more